semaglutide cardiovascular outcomes study news Recent at UC Irvine found that medication may benefit 93 million U.S. adults Effects of semaglutide on mortality,

Aderem, A

Studies have shown that MSM significantly reduces inflammation in your body

However, antihistamines can sometimes cause drowsiness and dryness, which might mimic signs of low blood sugar like dizziness and weakness

Dysbiosis can lead to the activation of pro-inflammatory pathways, such as the NF-B pathway, which in turn increases the production of cytokines and inflammatory mediators that compromise the BBB (Sanz and De Palma, 2009)

The Latest GLP-1 Oral Medication, Foundayo: What Employers Need to Know There's another important advance in obesity care: on April 1, 2026, the FDA approved Eli Lilly's oral medication Foundayo (orforglipron) for chronic weight management in adults with obesity, or overweight with at least one weight-related condition